CN107903233A - A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE - Google Patents

A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE Download PDF

Info

Publication number
CN107903233A
CN107903233A CN201810016141.0A CN201810016141A CN107903233A CN 107903233 A CN107903233 A CN 107903233A CN 201810016141 A CN201810016141 A CN 201810016141A CN 107903233 A CN107903233 A CN 107903233A
Authority
CN
China
Prior art keywords
dihydromyricetin
myricetin
ethyl acetate
extraction
herba shuteriae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810016141.0A
Other languages
Chinese (zh)
Inventor
肖世基
张茂生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zunyi Medical University
Original Assignee
Zunyi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zunyi Medical University filed Critical Zunyi Medical University
Priority to CN201810016141.0A priority Critical patent/CN107903233A/en
Publication of CN107903233A publication Critical patent/CN107903233A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40Separation, e.g. from natural material; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of new method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE.Its main feature is that using cheap HERBA SHUTERIAE as raw material, ethyl acetate is extracted by ethanol medicinal extract is obtained by extraction, obtained medicinal extract DIRECT GEL chromatographic isolation obtains myricetin and dihydromyricetin.This method is easy to operate, and sample loss is small, and recovery rate is high, is adapted to industrialized production.

Description

A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE
Technical field
The invention belongs to pharmaceutical technology field, specifically provides one kind and prepares myricetin and two by raw material extraction of HERBA SHUTERIAE The new method of hydrogen myricetin.
Background technology
Myricetin and dihydromyricetin have extensive pharmacological action, have great utility value.Pharmacological activity is previously Research confirms myricetin and dihydromyricetin has anti-oxidant, antitumor, anti-inflammatory, Antialcoholic liver-protecting, resisting pathogenic microbes and adjusts blood (Hou little Long, Wang Wenqing, apply spring sun-light, wait dihydromyricetin Advance on Pharmacological Activities for many pharmacological actions such as fat [J] Chinese herbal medicines, 2015,46 (4): 603-609.) .
HERBA SHUTERIAE is pulse family Shuteria vegetable hair place bud beansShuteria pampaninianaHand.-Mazz. dry Band base of leaf rattan,《Chinese medicine resource will will》Recording hair place bud beans has purging liver-heat, except steaming peaceful cough effect, for deficiency of Yin hectic fever, Tuberculosis cough, acute mastitis.Research shows that myricetin and dihydromyricetin are its active ingredient.At present domestic literature report to shuteria pampaniniana Myricetin and dihydromyricetin separation method mainly use decocting, polyamide column separation, the method complex process, extraction in rattan The bad processing of liquid, material consumption is big, yield is low(Cao Yanhuai, Huang expedition, fourth found flavone component [J] China in raw HERBA SHUTERIAEs J Chinese, 2000,25 (5): 290-291).
The content of the invention
It is an object of the invention to provide a kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE.
The technical solution used for:Include the following steps:
(1)HERBA SHUTERIAE powder is taken, adds 70-95% ethanol heating and refluxing extraction 1-5 times, adds distilled water after ethanol extract is concentrated It is allowed to scattered, then is extracted with ethyl acetate 1-5 times, ethyl acetate extract layer is concentrated to give HERBA SHUTERIAE ethyl acetate extract medicinal extract;
(2)The directly upper gel column chromatography of ethyl acetate extract medicinal extract dissolving, the elution of 50-100% methanol, collects eluent 15-30 altogether Part, you can extraction separating dihydromyricetin and myricetin.
Further, the step(1) in, the alcohol reflux for adding 80-90% extracts 2-3 times, when extraction 2~5 is small every time.
Further, the step(2) in, gel column chromatography is Sephadex LH-20 column chromatographys, the use of eluant, eluent is 90- 100% methanol.
The present invention extracts isolated myricetin and dihydromyricetin from HERBA SHUTERIAE, and gained dihydromyricetin purity reaches 92%, myricetin purity reaches 97%.The method of the present invention using cheap HERBA SHUTERIAE as raw material, can be greatly lowered bulk pharmaceutical chemicals into This, provides new extraction source for myricetin and dihydromyricetin, is also compound myricetin and dihydromyricetin standard items Preparation provide new method.
Brief description of the drawings
The structure chart of Fig. 1 myricetins and dihydromyricetin;
Fig. 2 is dihydromyricetin prepared by the embodiment of the present invention 1H-NMR spectrograms;
Fig. 3 is dihydromyricetin prepared by the embodiment of the present invention13C-NMR spectrograms;
Fig. 4 prepares myricetin for the embodiment of the present invention 1H-NMR spectrograms;
Fig. 5 prepares myricetin for the embodiment of the present invention13C-NMR spectrograms.
Embodiment
The present invention is further described with reference to embodiment and attached drawing, but the present invention is not limited only to following embodiments, can be with Those skilled in the art are predicted in the case where combining the prior art, there may be many variations for performance.
Embodiment 1
(1)100 g of HERBA SHUTERIAE powder is taken, adds 80% ethanol heating and refluxing extraction 3 times, after ethanol extract concentration plus distilled water makes It is scattered, it is extracted with ethyl acetate 2 times, ethyl acetate extract layer is concentrated to give 12 g of HERBA SHUTERIAE ethyl acetate extract medicinal extract.
(2)Ethyl acetate extract medicinal extract is dissolved with methanol, upper Sephadex LH-20 gel filtration chromatographies, the elution of 90% methanol, 30 parts of eluent is collected altogether.
(3)Cut 13 is dihydromyricetin, and 25 be myricetin.
Embodiment 2
(1)500 g of HERBA SHUTERIAE disk powder is taken, adds 90% ethanol heating and refluxing extraction 2 times, adds distilled water after ethanol extract concentration It is allowed to scattered, is extracted with ethyl acetate 2 times, ethyl acetate extract layer is concentrated to give 54 g of HERBA SHUTERIAE ethyl acetate extract medicinal extract.
(2)Ethyl acetate extract medicinal extract methanol dissolves, upper Sephadex LH-20 gel filtration chromatographies, the elution of 100% methanol, 30 parts of eluent is collected altogether.
(3)Cut 12 is dihydromyricetin, and 23 be myricetin.
The Structural Identification of compound
The present invention extracts isolated myricetin and dihydromyricetin by systematic solvent extraction and gel chromatography technology from HERBA SHUTERIAE Element, through physics and chemistry constant measuring and spectrum analysis, identification obtains their structure, such as attached drawing 1- attached drawings 5.
Dihydromyricetin:White powder, ESI-MSm/z:321 [M+H]+1H-NMR (400 MHz, DMSO-d 6)δ: 11.9 (1H, s, 5-OH), 6.39 (2H, s, H-2', 6'), 5.90, 5.86 (each 1H, br. s, H- 6, 8), 5.76 (1H, d, J = 6.0 Hz, 3- OH), 4.90 (1H, d, J = 10.8 Hz, H-2), 4.41 (1H, dd, J= 10.8, 6.0 Hz, H-3);13C-NMR (100 MHz, DMSO-d 6) δ: 83.2 (C-2), 71.6 (C-3), 197.7 (C-4), 163.3 (C-5), 95.9 (C-6), 166.8 (C-7), 95.0 (C-8), 162.5 (C-9), 100.5 (C-10), 127.1 (C-1'), 106.9 (C-2', 6'), 145.7 (C-3', 5'), 133.4 (C-4')。
Myricetin:Yellow powder, ESI-MSm/z:319 [M+H]+1H-NMR (400 MHz, DMSO-d 6) δ: 12.5 (1H, s, 5-OH), 7.24 (2H, s, H-2', 6'), 6.37 (1H, d, J = 1.9 Hz, H-8), 6.18 (1H, d, J= 1.9 Hz, H-6);13C-NMR (100 MHz, DMSO-d 6) δ: 146.8 (C-2), 135.9 (C-3), 175.8 (C-4), 160.7 (C-5), 98.2 (C-6), 163.9 (C-7), 93.2 (C-8), 156.1 (C-9), 103.0 (C-10), 120.8 (C-1'), 107.2 (C-2', 6'), 145.7 (C-3', 5'), 135.9 (C-4')。
The present invention is using cheap HERBA SHUTERIAE as raw material, and by extraction, gel chromatography separation obtains the poplar of high-purity Syphilis and dihydromyricetin, are greatly lowered the separation and Extraction cost of compound, are carried for the preparation of myricetin and dihydromyricetin New method is supplied.

Claims (3)

  1. A kind of 1. method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE, it is characterised in that include the following steps:
    (1)HERBA SHUTERIAE powder is taken, adds 70-95% ethanol heating and refluxing extraction 1-5 times, adds distilled water after ethanol extract is concentrated It is allowed to scattered, then is extracted with ethyl acetate 1-5 times, ethyl acetate extract layer is concentrated to give HERBA SHUTERIAE ethyl acetate extract medicinal extract;
    (2)The directly upper gel column chromatography of ethyl acetate extract medicinal extract dissolving, the elution of 50-100% methanol, collects eluent 15-30 altogether Part, you can obtain extracting separated dihydromyricetin and myricetin.
  2. 2. method as claimed in claim 1, it is characterised in that the step(1) in, the alcohol reflux extraction of 80-90% is added 2-3 times, when extraction 2~5 is small every time.
  3. 3. method as claimed in claim 1, it is characterised in that the step(2) in, gel column chromatography is Sephadex LH- 20 column chromatographys, are 90-100% methanol using eluant, eluent.
CN201810016141.0A 2018-01-08 2018-01-08 A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE Pending CN107903233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810016141.0A CN107903233A (en) 2018-01-08 2018-01-08 A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810016141.0A CN107903233A (en) 2018-01-08 2018-01-08 A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE

Publications (1)

Publication Number Publication Date
CN107903233A true CN107903233A (en) 2018-04-13

Family

ID=61872290

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810016141.0A Pending CN107903233A (en) 2018-01-08 2018-01-08 A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE

Country Status (1)

Country Link
CN (1) CN107903233A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101336978A (en) * 2008-08-12 2009-01-07 西北农林科技大学 Extraction method of total flavone of Hovenia dulcisThunb

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101336978A (en) * 2008-08-12 2009-01-07 西北农林科技大学 Extraction method of total flavone of Hovenia dulcisThunb

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张梅等: "川产中药材草红藤质量标准研究", 《成都中医药大学学报》 *
曹延怀等: "草红藤中的黄酮成分", 《中国中药杂志》 *

Similar Documents

Publication Publication Date Title
Guo et al. Preparative isolation and purification of four flavonoids from the petals of Nelumbo nucifera by high‐speed counter‐current chromatography
CN101139373B (en) Method for rapid scale extraction and purification of flax lignan
CN106242953A (en) A kind of method preparing resveratrol from phoenix seed of Flos Moutan shell
CN102526127B (en) Flash type extraction method for active constituents in cordyceps militaris
CN104529983B (en) Corm Eleocharitis skin extracts the method for eriodictyol
CN106008445B (en) Flavone and lignan compound and its extracting method
CN105585600B (en) A kind of preparation method of disconnected oxidation loganin
CN109320571A (en) The method for extracting luteolin kind compound and cynaropicrin
CN104592185B (en) Method for extracting quercetin from eleocharis tuberosa peels
CN1268631C (en) Technique for preparing general flavone of Chinese globeflower with short petal some medicinal substances in high purity
CN108299368B (en) Flavonoid compound and preparation method and application thereof
CN114989064B (en) Novel pyrrole alkaloid compound in purslane and extraction and separation method thereof
CN107903233A (en) A kind of method of extraction separation myricetin and dihydromyricetin from HERBA SHUTERIAE
CN102977066A (en) Method for extracting and purifying isoflavones in soybean
CN102772501A (en) Rheum emodi Wall. extract and its preparing method
CN105384784B (en) The screening of three kinds of antioxidation activity 2,3,5,4'-tetrahydroxyl diphenylethylene-2-O-BETA-D-glucoside class materials, method for separating and preparing in the Qinghai cultivation fleece-flower root
CN105085453B (en) A kind of utilization high-speed countercurrent chromatography method that separation prepares oligomeric stilbene compound from Chinese small iris
CN108658770B (en) Method for preparing chlorogenic acid monomer from black diamond potatoes
CN102241656A (en) Preparation method of tricin
CN107445971A (en) A kind of method of the extraction separation eupatolide from sunflower plate
CN104557824B (en) Method for extracting aureusidin from eleocharis tuberosa peels
CN108083993A (en) A kind of curvature of the spinal column stem of noble dendrobium ingredient and its preparative separation method
CN104592180B (en) Method for extracting 5-methyl aureusidin from eleocharis tuberosa peels
CN114989083B (en) Novel isoquinoline alkaloid in purslane and extraction and separation method thereof
WO2017139962A1 (en) Method for extracting herbacetin from rhodiola rosea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180413

WD01 Invention patent application deemed withdrawn after publication